Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time

Authors

  • Di Maria Jiang
  • Robert J. Hamilton
  • Aaron R. Hansen

DOI:

https://doi.org/10.5489/cuaj.6407

Keywords:

Chemotherapy intensification, standard of care, poor-risk non-seminomatous germ cell tumor

Downloads

Download data is not yet available.

Downloads

Published

2020-01-30

How to Cite

Jiang, D. M. ., Hamilton, R. J. ., & Hansen, A. R. . (2020). Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time . Canadian Urological Association Journal, 14(2), 48–9. https://doi.org/10.5489/cuaj.6407

Issue

Section

Commentary